Better than natural: next-generation therapeutics through advanced protein engineering
The November issue of Nature’s Biopharma Dealmakers includes an article that highlights how our CodeEvolver® technology platform can overcome the suboptimal properties and limitations of natural proteins by generating novel biological variants with safety and efficacy profiles specifically tailored to target diseases.
Download